Home page

CARDIOPROGRESS
Foundation for the advancement of cardiology

Knowledge, observation, action

  РУС

Feedback

RU EN
  •  About Foundation 
  •  Scientific news 
  •   Events  
  •   Projects  
  •   Guidelines  
  •   Trials  
  •   Editorial activity  
  •   Archive  
  • Главная
  •   Events  
  • Russian cardio events

Russian cardio events

 


Russian scientific events 2024



Russian scientific events 2022



Russian scientific events 2021



Russian scientific events 2020



Russian scientific events 2016



Russian scientific events 2015



Russian scientific events 2013


Scientific news

  • Prolactin Tied to Poorer Diastolic Function in Men With Type 2 Diabetes Higher prolactin levels were associated with poorer diastolic function and worse New York Heart Association functional class, a marker of heart failure severity, in men with type 2 diabetes but not in women. However, prolactin showed no association with systolic function, lipid levels, or A1c levels in either sex.

  • Ovarian Reserve Decline Patterns Linked to Cardiovascular Risk After Menopause According to a new study, patterns of decreased ovarian reserve during the transition to menopause may be associated with cardiovascular risk after menopause.

  • Bipolar Disorder Linked to Higher Risk for Cardiovascular Disease A meta-analysis has shown that adults with bipolar disorder (BPD) have a significant number of cardiovascular diseases (CVD). Controlled observational studies have shown a higher incidence of cardiovascular complications among people with BPD than among people without BPD.

  • Healthy Diet May Curb Heart Disease Risk in Cancer Survivors Cancer survivors who adhered to the Dietary Approaches to Stop Hypertension (DASH) diet and other healthy eating patterns showed as much as a one-third lower risk of developing cardiovascular disease over 12 years vs their peers who did not follow those dietary patterns.

  • Timeless therapeutics: cardiac indications for vitamin K antagonists in clinical practice Anticoagulation is a critical component in the treatment of cardiovascular diseases. Large randomised controlled trials have demonstrated that direct oral anticoagulants (DOACs) are effective and safe for stroke prevention in patients with atrial fibrillation (AF) and treatment or prevention of venous thromboembolism.

Partners

  • The Department of Health in Moscow
  • The State Committee on Health
  • Silicea-Poligraf, publishing house

Video resource

Channel "Cardioprogress"

Follow us

Top.Mail.Ru

© 2012-2018 Foundation for the advancement of cardiology «Cardioprogress»